We also observed a marginally significant negative correlation between the R-index and cell number in the intermittent administration (0, 1, 2, 4, 9, and 11 days) of erlotinib ( Figure S4 ).
← all excerpts
Stratification of non-small cell lung adenocarcinoma patients with EGFR actionable mutations based on drug-resistant stem cell genes.
1
—
—